An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells

Nature Biotechnology

Volumn 29, Issue 9, 2011, Pages 829-834

  Tang, Chad ^a   Lee, Andrew S ^a   Volkmer, Jens Peter ^a,b   Sahoo, Debashis ^a   Nag, Divya ^a   Mosley, Adriane R ^a   Inlay, Matthew A ^a   Ardehali, Reza ^a   Chavez, Shawn L ^a   Pera, Renee Reijo ^a   Behr, Barry ^a   Wu, Joseph C ^a   Weissman, Irving L ^a   Drukker, Micha ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOINFORMATICS ANALYSIS; CLINICAL APPLICATION; CONCURRENT EXPRESSION; DIFFERENTIATED CULTURES; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNODEPLETION; IMMUNOHISTOCHEMISTRY; MICROARRAY DATABASE; PLURIPOTENCY; PLURIPOTENT STEM CELLS; SURFACE MARKERS; UNDIFFERENTIATED CELLS;

ANTIGENS; BIOINFORMATICS; MONOCLONAL ANTIBODIES; STEM CELLS; TUMORS;

CELL CULTURE;

BONE MORPHOGENETIC PROTEIN 4; CD200 ANTIGEN; CD30 ANTIGEN; CD9 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 3; MONOCLONAL ANTIBODY; RETINOIC ACID; STAGE SPECIFIC EMBRYO ANTIGEN; STAGE SPECIFIC EMBRYO ANTIGEN 5; THY 1 ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; EXPLANT; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; KIDNEY; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; TERATOMA; TUMOR GROWTH;

ANIMALS; ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELLS, CULTURED; COMPUTATIONAL BIOLOGY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; MICROARRAY ANALYSIS; PLURIPOTENT STEM CELLS; POLYSACCHARIDES; REAL-TIME POLYMERASE CHAIN REACTION; STAGE-SPECIFIC EMBRYONIC ANTIGENS; TERATOMA;

EID: 80052749542     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.1947     Document Type: Article

References (32)

1. Blum, B. & Benvenisty, N. The tumorigenicity of human embryonic stem cells. Adv. Cancer Res. 100, 133-158 (2008). (Pubitemid 351932182)
2. Tang, C. & Drukker, M. Potential barriers to therapeutics utilizing pluripotent cell derivatives: intrinsic immunogenicity of in vitro maintained and matured populations. Semin. Immunopathol. published online, doi: 10.1007/s00281-011-0269-5 (11 April 2011).
3. Schuldiner, M., Itskovitz-Eldor, J. & Benvenisty, N. Selective ablation of human embryonic stem cells expressing a "suicide" gene. Stem Cells 21, 257-265 (2003). (Pubitemid 36623167)
4. Cao, F. et al. Molecular imaging of embryonic stem cell misbehavior and suicide gene ablation. Cloning Stem Cells 9, 107-117 (2007). (Pubitemid 46642075)
5. Choo, A.B. et al. Selection against undifferentiated human embryonic stem cells by a cytotoxic antibody recognizing podocalyxin-like protein-1. Stem Cells 26, 1454-1463 (2008).
6. Tan, H.L., Fong, W.J., Lee, E.H., Yap, M. & Choo, A. mAb 84, a cytotoxic antibody that kills undifferentiated human embryonic stem cells via oncosis. Stem Cells 27, 1792-1801 (2009).
7. Drukker, M., Muscat, C. & Weissman, I.L. Generation of a monoclonal antibody library against human embryonic stem cells. Methods Mol. Biol. 407, 63-81 (2007).
8. Andrews, P.W., Banting, G., Damjanov, I., Arnaud, D. & Avner, P. Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells. Hybridoma , 347-361 (1984). (Pubitemid 15126239)
9. Shevinsky, L.H., Knowles, B.B., Damjanov, I. & Solter, D. Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells. Cell 30, 697-705 (1982). (Pubitemid 13204659)
10. Kannagi, R. et al. Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. EMBO J. 2, 2355-2361 (1983).
11. Thomson, J.A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (1998). (Pubitemid 28516247)
12. Reubinoff, B.E., Pera, M.F., Fong, C.Y., Trounson, A. & Bongso, A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol. 18, 399-404 (2000). (Pubitemid 30217526)
13. Behr, B. et al. Blastocyst-ET and monozygotic twinning. J. Assist. Reprod. Genet. 17, 349-351 (2000).
14. Stevens, L.C. & Little, C.C. Spontaneous testicular teratomas in an inbred strain of mice. Proc. Natl. Acad. Sci. USA 40, 1080-1087 (1954).
15. Hentze, H. et al. Teratoma formation by human embryonic stem cells: Evaluation of essential parameters for future safety studies. Stem Cell Res. 2, 198-210 (2009).
16. Wu, J.C., Sundaresan, G., Iyer, M. & Gambhir, S.S. Noninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice. Mol. Ther. 4, 297-306 (2001). (Pubitemid 33040513)
17. Lee, A.S. et al. Effects of cell number on teratoma formation by human embryonic stem cells. Cell Cycle 8, 2608-2612 (2009).
18. Vodyanik, M.A. & Slukvin, II. Hematoendothelial differentiation of human embryonic stem cells. Curr. Protoc. Cell Biol. 36, 23.6.1-23.6.28 (2007).
19. Nagano, K., Yoshida, Y. & Isobe, T. Cell surface biomarkers of embryonic stem cells. Proteomics 8, 4025-4035 (2008).
20. Raman, R. et al. Advancing glycomics: implementation strategies at the consortium for functional glycomics. Glycobiology 16, 82R-90R (2006).
21. Torrado, J., Gutierrez Hoyos, A., Blasco, E., Larraz, J. & Fernandez Rivas, J.L. Immunohistological patterns of blood group ABO and type 1 chain (Lewis a Lewis b) and type 2 chain (H-2, Y) antigens in normal uterine cervix. Tissue Antigens 36, 8-11 (1990). (Pubitemid 20270513)
22. Rosler, E.S. et al. Long-term culture of human embryonic stem cells in feeder-free conditions. Dev. Dyn. 229, 259-274 (2004). (Pubitemid 38140465)
23. Mateizel, I. et al. Characterization of CD30 expression in human embryonic stem cell lines cultured in serum-free media and passaged mechanically. Hum. Reprod. 24, 2477-2489 (2009).
24. Draper, J.S., Pigott, C., Thomson, J.A. & Andrews, P.W. Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J. Anat. 200, 249-258 (2002). (Pubitemid 34467317)
25. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 (2007).
26. Sahoo, D. et al. MiDReG: a method of mining developmentally regulated genes using Boolean implications. Proc. Natl. Acad. Sci. USA 107, 5732-5737 (2010).
27. Inlay, M.A. et al. Ly6d marks the earliest stage of B-cell specification and identifies the branchpoint between B-cell and T-cell development. Genes Dev. 23, 2376-2381 (2009).
28. Solter, D. & Knowles, B.B. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc. Natl. Acad. Sci. USA 75, 5565-5569 (1978). (Pubitemid 9084529)
29. Hakomori, S. Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. Annu. Rev. Biochem. 50, 733-764 (1981).
30. Liang, Y.J. et al. Switching of the core structures of glycosphingolipids from globo- and lacto- to ganglio-series upon human embryonic stem cell differentiation. Proc. Natl. Acad. Sci. USA 107, 22564-22569 (2010).
31. Sahoo, D., Dill, D.L., Gentles, A.J., Tibshirani, R. & Plevritis, S.K. Boolean implication networks derived from large scale, whole genome microarray datasets. Genome Biol. 9, R157 (2008).
32. Goldman, J.P. et al. Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor gamma chain. Br. J. Haematol. 103, 335-342 (1998).